[go: up one dir, main page]

NO942813D0 - Spröytekjölt nabumeton - Google Patents

Spröytekjölt nabumeton

Info

Publication number
NO942813D0
NO942813D0 NO942813A NO942813A NO942813D0 NO 942813 D0 NO942813 D0 NO 942813D0 NO 942813 A NO942813 A NO 942813A NO 942813 A NO942813 A NO 942813A NO 942813 D0 NO942813 D0 NO 942813D0
Authority
NO
Norway
Prior art keywords
pct
spray
nabumeton
peeled
sec
Prior art date
Application number
NO942813A
Other languages
English (en)
Norwegian (no)
Other versions
NO942813L (no
Inventor
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO942813L publication Critical patent/NO942813L/no
Publication of NO942813D0 publication Critical patent/NO942813D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coating By Spraying Or Casting (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Freezing, Cooling And Drying Of Foods (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Catching Or Destruction (AREA)
  • Road Signs Or Road Markings (AREA)
NO942813A 1992-01-29 1994-07-28 Spröytekjölt nabumeton NO942813D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929201857A GB9201857D0 (en) 1992-01-29 1992-01-29 Novel compound
PCT/GB1993/000145 WO1993014747A1 (en) 1992-01-29 1993-01-22 Spray-chilled nabumetone

Publications (2)

Publication Number Publication Date
NO942813L NO942813L (no) 1994-07-28
NO942813D0 true NO942813D0 (no) 1994-07-28

Family

ID=10709436

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942813A NO942813D0 (no) 1992-01-29 1994-07-28 Spröytekjölt nabumeton

Country Status (24)

Country Link
US (1) US5539000A (pt)
EP (1) EP0624087B1 (pt)
JP (1) JPH07503245A (pt)
KR (1) KR950700056A (pt)
CN (1) CN1079954A (pt)
AT (1) ATE150298T1 (pt)
AU (1) AU3362693A (pt)
BG (1) BG98933A (pt)
BR (1) BR9305674A (pt)
CA (1) CA2129027A1 (pt)
CZ (1) CZ182894A3 (pt)
DE (1) DE69309037T2 (pt)
DK (1) DK0624087T3 (pt)
ES (1) ES2099419T3 (pt)
FI (1) FI943550A0 (pt)
GB (1) GB9201857D0 (pt)
GR (1) GR3023142T3 (pt)
HU (1) HUT67462A (pt)
IL (1) IL104526A0 (pt)
MX (1) MX9300430A (pt)
NO (1) NO942813D0 (pt)
SK (1) SK91694A3 (pt)
WO (1) WO1993014747A1 (pt)
ZA (1) ZA93577B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB9920148D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel composition
US6436990B1 (en) 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
US6552078B2 (en) 1999-10-27 2003-04-22 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
TWI262791B (en) 1999-10-27 2006-10-01 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US20020132010A1 (en) * 2000-12-22 2002-09-19 Yihong Qui Divalproex sodium dosage forms and a process for their production
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20060083791A1 (en) * 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
WO2005053656A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
AU2004294818A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
RU2006119464A (ru) * 2003-12-04 2007-12-20 Пфайзер Продактс Инк. (Us) Способ распыления-охлаждения с применением экструдера для получения композиций азитромицина в мультичастицах, предпочтительно содержащих полоксамер и глицерид
SI1691787T1 (sl) * 2003-12-04 2008-10-31 Pfizer Prod Inc Postopek za pripravo farmacevtskih produktov iz več delcev
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
EP1691786A1 (en) * 2003-12-04 2006-08-23 Pfizer Products Inc. Multiparticulate compositions with improved stability
EP1809305A4 (en) * 2004-10-15 2009-12-30 Altairnano Inc PHOSPHATE BINDER WITH REDUCED TABLE TAKING
AU2006279343A1 (en) * 2005-08-17 2007-02-22 Altairnano, Inc. Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods
US8436051B2 (en) 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) * 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
CA2798081C (en) 2010-05-12 2024-02-13 Spectrum Pharmaceuticals, Inc. Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
EP3824296A4 (en) 2018-07-20 2022-04-27 Lipocine Inc. LIVER DISEASE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474377A (en) 1973-09-11 1977-05-25 Beecham Group Ltd Naphthalene derivatives
US4420639C1 (en) * 1973-09-11 2001-08-21 Beecham Group Ltd Aromatic compounds
US4086346A (en) 1974-04-06 1978-04-25 Bayer Aktiengesellschaft Preparation of melt-sprayed spherical phenacetin granules
DE3833446A1 (de) * 1988-10-01 1990-04-05 Hoechst Ag Verfahren zur herstellung von arzneimittelwirkstoff-partikeln mit verbesserten fliess-, lager- und formulierungseigenschaften sowie arzneimittel, die diese arzneimittelwirkstoff-partikeln enthalten

Also Published As

Publication number Publication date
ATE150298T1 (de) 1997-04-15
DE69309037T2 (de) 1997-07-24
BG98933A (en) 1995-07-28
HUT67462A (en) 1995-04-28
WO1993014747A1 (en) 1993-08-05
EP0624087A1 (en) 1994-11-17
CA2129027A1 (en) 1993-08-05
BR9305674A (pt) 2005-01-11
KR950700056A (ko) 1995-01-16
US5539000A (en) 1996-07-23
MX9300430A (es) 1994-08-31
GR3023142T3 (en) 1997-07-30
EP0624087B1 (en) 1997-03-19
DE69309037D1 (de) 1997-04-24
GB9201857D0 (en) 1992-03-18
FI943550L (fi) 1994-07-28
FI943550A7 (fi) 1994-07-28
HU9402221D0 (en) 1994-09-28
IL104526A0 (en) 1993-05-13
DK0624087T3 (da) 1997-09-01
AU3362693A (en) 1993-09-01
SK91694A3 (en) 1995-03-08
ES2099419T3 (es) 1997-05-16
FI943550A0 (fi) 1994-07-28
CZ182894A3 (en) 1995-02-15
NO942813L (no) 1994-07-28
JPH07503245A (ja) 1995-04-06
ZA93577B (en) 1994-01-13
CN1079954A (zh) 1993-12-29

Similar Documents

Publication Publication Date Title
NO942813D0 (no) Spröytekjölt nabumeton
EP0602790A3 (en) Directing operation of computer systems.
EG21672A (en) Dihalopropene compounds insecticidal acaricidal agent containing same and intermediates for their production
NZ325791A (en) 5-amino-3-cyano-4-ethylsulphinyl-1-phenyl-pyrazole compounds and pesticides containing them
PH31249A (en) Inhibitors of hiv protease.
NO982567D0 (no) Forbedret hydrogenolyse av 2,4,6,8,10,12-heksaazatetracyklo (5.5.0.05.903.11) dodekan
IL99214A0 (en) Hypoglycemic hydroxyurea derivatives
GR3035574T3 (en) Use of substituted benzimidazoles.
NZ312327A (en) Controlling hemipteran insect pests with bacillus thuringiensis
ZA968895B (en) Hydroformylation process of ethylenically unsaturated compounds.
HUT64204A (en) Method and tool for dosing liquid product
MX9709398A (es) N-aril-1,2,4-triazolin-5-onas.
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
TW341494B (en) Fungicidal mixtures
SE9301831D0 (sv) Pharmaceutical compositions
AU7962091A (en) Phenyl 4-guanidinobenzoate derivative, process for producing the same, and protease inhibitor containing the same
TW342311B (en) Fungicidal mixtures
ZA94546B (en) Switch protection arrangement
TW366338B (en) Arylalkoxyphenoxy-imidazoline compounds
US5647301A (en) Method for planting fish eggs and a planting tube for carrying out the method
AU6221096A (en) Terpenes for reducing the effect of pheromone on lepidoptera
NO954115L (no) Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis
AP9200409A0 (en) Sasakwa gari processor.
EP0799176A4 (en) 4.4- (DISUBSTITUTED) CYCLOHEXAN-1-ONE DIMERS AND RELATED COMPOUNDS
ES1021888Y (es) Manguera contra incendios.